Core Insights - Fangzhou Jianke has been awarded the "Intelligent Driving Future Award," highlighting its leadership in chronic disease services and recognition within the healthcare industry [1][5] - The T-Inspire CIO private meeting, hosted by Tencent Health, aims to explore new digital pathways in the healthcare industry, gathering top companies from various sectors [2] Company Overview - Fangzhou Jianke is recognized as a leading smart healthcare service platform in China, focusing on innovation to empower its business [2] - The company has developed a MaaS (Medicine as a Service) system, combining patient trust with strong service capabilities to transform chronic disease services into scalable solutions [2][3] Technological Advancements - The company has successfully broken traditional barriers in healthcare, enhancing accessibility to quality medical resources through technology [3] - Fangzhou Jianke has upgraded its service model from a single human-driven approach to an algorithm-driven, responsive, and refined service system [3] Business Performance - The company is expected to achieve a revenue of 3.5 billion to 3.55 billion yuan in 2025, reflecting a significant year-on-year growth of 30% [5] - The strong foundation of "familiar doctor-patient" relationships is translating into substantial commercial value and operational momentum [5] Future Outlook - Fangzhou Jianke plans to continue enhancing its MaaS system and improve the depth and reach of chronic disease services, aligning with the "Healthy China 2030" strategy [5]